NCT06027905Completed
Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate
Source: ClinicalTrials.gov · Last updated 17 Sept 2025
Brief summary (registry, in English)
This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 445 (actual)
- First submitted
- 21 Aug 2023
- Start date
- 13 Sept 2023
- Primary completion date
- 1 Nov 2024
- Lead sponsor
- Rush University Medical Center
- Diseases
- High blood pressure
- NCT number
- NCT06027905
What you commit to
- Study type: Interventional
- Participants enrolled: 445
- From 13 Sept 2023 to the primary completion date, 1 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Organ transplant recipient
Other
- Dialysis patient
Who the study is looking for
- African American and/or Latinx self-identifying
- Stage II hypertension (140/90) or greater
- Following with Rush primary care provider in eligible Rush primary care clinic
- Access to phone or device with video capabilities in the home
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rush University Medical Center Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.